Venetoclax-based chemotherapy failure in adult T-cell acute lymphoblastic leukemia with NUP98::ADD3 fusion: a case report
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06702-6 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Ting Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, …. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Nuclear Pore Complex Proteins, Oncogene Proteins, Fusion. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Beijing Municipal Administration of Hospitals Incubating Program, Beijing Chao-Yang Hospital Golden Seeds Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
NUP98 fusions are molecularly rare in T-cell acute lymphoblastic leukemia (T-ALL), with limited data available regarding treatment response and clinical outcomes. Here, we report a case of T-ALL harboring a NUP98::ADD3 fusion (involving NUP98 exon 13 and ADD3 exon 13), representing only the second documented instance of this genetic rearrangement in T-ALL. Notably, the patient demonstrated refractoriness to venetoclax-based chemotherapy. To our knowledge, this is the first report of a T-ALL case with the NUP98::ADD3 fusion exhibiting resistance to venetoclax-containing regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China.
- Chinese Institutes for Medical Research, Beijing, 100005, China.
- Department of Pathology, Beijing ChaoYang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China.
- Department of Clinical Laboratory, Beijing ChaoYang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China.
- Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China. wudxuan@126.com.
- Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China. zhuhhdoc@163.com.
Förderung
- the National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals Incubating Program
- Beijing Chao-Yang Hospital Golden Seeds Foundation
- Beijing Hospitals Authority "Dengfeng" talent training plan
- Beijing Hospitals Authority “Dengfeng” talent training plan
Zitieren
APA
Shi, T., Cheng, Z., Zhang, Z., Jiang, X., Zhao, Y., Wu, Y., & Zhu, H. H. (2025). Venetoclax-based chemotherapy failure in adult T-cell acute lymphoblastic leukemia with NUP98::ADD3 fusion: a case report. Annals of Hematology. https://doi.org/10.1007/s00277-025-06702-6
Vancouver
Shi T, Cheng Z, Zhang Z, Jiang X, Zhao Y, Wu Y, et al. Venetoclax-based chemotherapy failure in adult T-cell acute lymphoblastic leukemia with NUP98::ADD3 fusion: a case report. Annals of Hematology. 2025. doi:10.1007/s00277-025-06702-6
BibTeX
@article{Shi2025,
author = {Shi, Ting and Cheng, Zhanrui and Zhang, Zhiyao and Jiang, Xingran and Zhao, Yantian and Wu, Yin and Zhu, Hong-Hu},
title = {Venetoclax-based chemotherapy failure in adult T-cell acute lymphoblastic leukemia with NUP98::ADD3 fusion: a case report},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06702-6}
}
EUVIMED